|
LFVN's Net Income Growth by Quarter and Year
Lifevantage's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| LFVN Net Income (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
June |
1.31
|
1.97
|
-1.42
|
4.91
|
| III Quarter |
March |
1.66
|
1.02
|
1.14
|
1.72
|
| II Quarter |
December |
-0.66
|
-1.06
|
0.08
|
3.81
|
| I Quarter |
September |
0.63
|
0.61
|
3.32
|
2.45
|
| FY |
|
2.94
|
2.54
|
3.12
|
12.89
|
| LFVN Net Income fourth quarter 2024 Y/Y Growth Comment |
Lifevantage Corp reported fall in Net Income in the fourth quarter 2024 by -33.76% to $ 1.31 millions, from the same quarter in 2023.
The drop in the fourth quarter 2024 Lifevantage Corp's Net Income compares unfavorably to the Company's average Net Income rise of 32.93%.
Looking into fourth quarter 2024 results within Major Pharmaceutical Preparations industry 14 other companies have achieved higher Net Income growth. While Lifevantage Corp' s Net Income drop of -33.76% ranks overall at the positon no. 762 in the fourth quarter 2024.
|
| LFVN Net Income ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
June |
-33.76 % |
- |
- |
28.53 % |
| III Quarter |
March |
62.75 % |
-10.53 % |
-33.72 % |
3.61 % |
| II Quarter |
December |
- |
- |
-97.9 % |
-11.4 % |
| I Quarter |
September |
3.28 % |
-81.63 % |
35.51 % |
39.2 % |
| FY |
|
15.55 % |
-18.59 % |
-75.8 % |
11.7 % |
LFVN Net Income (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
June |
-21.39 % |
93.14 % |
- |
185.47 % |
| III Quarter |
March |
- |
- |
1325 % |
-54.86 % |
| II Quarter |
December |
- |
- |
-97.59 % |
55.51 % |
| I Quarter |
September |
-68.02 % |
- |
-32.38 % |
-35.86 % |
| FY (Year on Year) |
|
15.55 % |
-18.59 % |
-75.8 % |
11.7 % |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 518.12 % |
32.93 % |
-108.92 % |
| (Sep 30 2023) |
|
(Mar 31 2023) |
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 518.12 % |
32.93 % |
-108.92 % |
| (Sep 30 2023) |
|
(Mar 31 2023) |
|
| Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Lifevantage's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 1534.45 % |
119.58 % |
-97.62 % |
| (Mar 31 2013) |
|
|
| LFVN's IV. Quarter Q/Q Net Income Comment |
In the IV. Quarter 2024 Lifevantage Corp reported fall in Net Income sequentially by -21.39% to $ 1.31 millions, from $ 1.66 millions released in the previous reporting period.
Those periodic circumstance which commonly fuel IV. Quarter 2024 performance, have not salvage the IV. Quarter for the Lifevantage Corp, Riley Moore, Healthcare sector researcher said, he cited some caution for the Lifevantage's perspective.
Within Major Pharmaceutical Preparations industry 16 other companies have achieved higher Net Income quarter on quarter growth. While Lifevantage's Net Income growth quarter on quarter, overall rank is 1266. |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 1534.45 % |
119.58 % |
-97.62 % |
| (Mar 31 2013) |
|
|
| LFVN's IV. Quarter Q/Q Net Income Comment |
In the IV. Quarter 2024 Lifevantage Corp realized fall in Net Income from the previous quarter by -21.39% to $ 1.31 millions, from $ 1.66 millions declared in the previous quarter.
Even periodic factors which usually fuel IV. Quarter 2024 performance, this plainly has not been substantial to rescue Lifevantage's IV. Quarter 2024 achievement, Riley Moore, Healthcare sector researcher pointed out and wrote that average sequential Net Income growth is at 119.58% for LFVN.
Within Major Pharmaceutical Preparations industry 16 other companies have achieved higher Net Income quarter on quarter growth. While Lifevantage's Net Income growth quarter on quarter, overall rank is 1266. |
|
Lifevantage's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
| Cumulative Net Income 12 Months Ending |
$ 2.94 |
$ 3.60 |
$ 2.96 |
$ 2.56 |
$ 2.54 |
| Y / Y Net Income Growth (TTM) |
15.63 % |
- |
- |
518.12 % |
-18.59 % |
| Year on Year Net Income Growth Overall
Ranking |
# 1002 |
# 1125 |
# 74 |
# 1620 |
# 1916 |
| Seqeuential Net Income Change (TTM) |
-18.37 % |
21.51 % |
15.71 % |
0.75 % |
- |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# 588 |
# |
# |
# 65 |
# 1465 |
| Cumulative Net Income growth
Comment |
Although Lifevantage's Annual Net Income growth year on year were below company's average 32.93% , Net Income announced in the Jun 30 2024 period, show improvement in Net Income trend, to cumulative trailing twelve month growth of 15.63% year on year, from % in Mar 31 2024.
In the Healthcare sector 74 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1002, from total ranking in previous quarter at 1125. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
518.12 % |
32.93 % |
-108.92 % |
| (Sep 30 2023) |
|
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
518.12 % |
32.93 % |
-108.92 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 16 |
| Sector |
# 68 |
| S&P 500 |
# 823 |
|
| Cumulative Net Income growth
Comment |
Although Lifevantage's Annual Net Income growth year on year were below company's average 32.93% , Net Income announced in the Jun 30 2024 period, show improvement in Net Income trend, to cumulative trailing twelve month growth of 15.63% year on year, from % in Mar 31 2024.
In the Healthcare sector 74 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1002, from total ranking in previous quarter at 1125. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
518.12 % |
32.93 % |
-108.92 % |
| (Sep 30 2023) |
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
518.12 % |
32.93 % |
-108.92 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 16 |
| Sector |
# 68 |
| S&P 500 |
# 823 |
|
